Policy & Regulation
23 September 2021 - - US-based Gilead Sciences, Inc. (NASDAQ: GILD) has posted positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of...
23 September 2021 - - Brazil's regulatory authority, ANVISA (Agência Nacional de Vigilância Sanitária), has approved the start of an additional Phase 3 CD16 clinical trial of l...
23 September 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has completed dosing of 100 subjects for the Phase 1 portion of the ARC...
23 September 2021 - Scientific tool company Zymo Research reported on Thursday the receipt of the CE IVD Mark for its EZ DNA Methylation-Lightning Kit for distribution within the European Union (EU) c...
23 September 2021 - Canada-based biotechnology company AbCellera (Nasdaq: ABCL) has signed a multi-year collaboration and license agreement with Everest Medicines Limited (HKEX 1952.HK), a biopharmace...
23 September 2021 - Chicago-based Rosalind Franklin University of Medicine and Science (RFU) and Aptinyx, a US-based clinical-stage biopharmaceutical company, have entered into a research collaboratio...